Abstract
In a previous study (Rammsayer & Vogel, 1991), rats selectively bred for high and low catecholamine responses to stress showed a selective response to the 5-HT2 receptor blocker ritanserin. However, it remained unclear whether selective breeding resulted in a decrease in 5-HT responsivity, as suggested by the lack of an effect in high stress responding rats, or in an increase in 5-HT responsivity, as suggested by ritanserin-induced reduction in alcohol intake in low-responding rats. To answer this question, nonselectively bred rats were forced to drink a 5% alcohol solution for 10 days. For the subsequent six days, animals were injected subcutaneously with 2.5 mg/kg/2 ml ritanserin or vehicle only, and both a 5% solution of alcohol and water were presented to the animals. Ritanserin neither affected alcohol nor total fluid intake suggesting that in the general population of N/NIH (Hansen) rats as well as in rats of the same strain selectively bred for high catecholamine responses, mesolimbic dopaminergic activity is not effectively modulated by specific blockade of 5-HT2 receptors. However, a very pronounced ritanserin induced difference in daily water intake between nonbred male and female rats became evident.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Awouters, F., Niemegeers, C.J.E., Megens, A.A.H.P., Meert, T.H., & Janssen, P.A.J. (1988). The pharmacological profile of ritanserin, a very specific central serotonin-S2 antagonist.Drug Development Research, 15, 61–73.
Backus, L.I., Sharp, T., & Grahame-Smith, D.G. (1989). Behavioural evidence for a functional interaction between central 5-HT2 and 5-HT1A receptors. International Symposium on Serotonin from Cell Biology to Pharmacology and Therapeutics, Florence, March 29–April 1, Abstract book, 40.
Bozarth, M.A. (1987). Ventral tegmental reward system. In J. Engel, L. Oreland, D. H. Ingvar, B. Pernow, S. Rössner, L. Å. Pellborn (Eds.),Brain reward systems and abuse (pp. 1–33). New York: Raven Press.
Casteneda, R. & Cushman, P. (1989). Alcohol withdrawal: A review of clinical management.Journal of Clinical Psychiatry, 50, 278–284.
Fadda, F., Garau, B., Marchei, F., Colombo, G., & Gessa, G.L. (1991). MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rats.Alcohol and Alcoholism, 26, 107–110.
Fibiger, H.C. & Phillips, A.G. (1986). Reward, motivation, cognition: Psychobiology of mesotelencephalic dopamine systems. In American Physiological Society (Ed.),Handbook of physiology. Section 1. The nervous system. Vol. IV. Intrinsic regulatory systems of the brain (pp. 647–675). Bethesda, Maryland: American Physiological Society.
Gongwer, M.A., Murphy, J.M., McBride, WJ., Lumeng, L. & Li, T.-K. (1989). Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats.Alcohol, 6, 317–320.
Goodwin, G.M. & Green, A.R. (1985). A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.British Journal of Pharmacology, 84, 743–753.
Haleem, D.J. (1992). Sex differences in neurochemical and behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin.Life Sciences, 50, PL221–226.
Higgins, G.A., Tomkins, D.M., Fletcher, P.J., & Sellers, E.M. (1992). Effect of drugs influencing 5-HT function on ethanol drinking and feeding behaviour in rats: Studies using a drinkometer system.Neuroscience and Biobehavioral Reviews, 16, 535–552.
Hodge, C.W., Samson, H.H., Lewis, R.S., & Erickson, H.L. (1993). Specific decreases in ethanol- but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930.Alcohol, 10, 191–196.
Idzikowski, C., Mills, D.W., & Glennard, R. (1986). 5-hydroxytryptamine-2 antagonist increases human slow wave sleep.Brain Research, 378, 164–168.
Johanson, C.-E. & Fischman, M.W. (1989). The pharmacology of cocaine related to its abuse.Pharmacological Reviews, 41, 3–52.
Knapp, D. J. & Pohorecky, L. A. (1992). Zacopride, a 5-HT3 receptor antagonist, reduces voluntary ethanol consumption in rats.Pharmacology, Biochemistry and Behavior, 41, 847–850.
Knapp, D. J., Benjamin, D., & Pohorecky, L. A. (1992). Effects of gepirone on ethanol consumption, exploratory behavior, and motor performance in rats.Drug Development Research, 26, 319–341.
Kostowski, W. & Dyr, W. (1992). Effects of 5-HT1A receptor agonists on ethanol preference in the rat.Alcohol, 9, 283–286.
Kostowski, W., Dyr, W., & Krzascik, P. (1993). The abilities of 5-HT3 receptor antagonist ICS 205-930 to inhibit alcohol preference and withdrawal seizures in rats.Alcohol, 10, 369–373.
Lakoski, J.M. & Aghajanian, G.K. (1985). Effects of ketanserin on neuronal responses to serotonin in the prefrontal cortex, lateral geniculate and dorsal raphe nucleus.Neuropharmacology, 24, 265–273.
Lawrin, M.O., Naranjo, C.A., & Sellers, E.M. (1985). Enhanced serotonergic neurotransmission decreases ethanol consumption. Consistent results with a serotonin agonist.Proceedings of the Canadian Federated Biological Society, 28, 81.
McBride, W. J., Murphy, J. M., Lumeng, L. & Li, T.-K. (1990). Serotonin, dopamine and GABA involvement in alcohol drinking of selectively bred rats.Alcohol, 7, 199–205.
Meert, T. & Janssen, P.A.J. (1989). Psychopharmacology of ritanserin: Comparison with chlordiazepoxide.Drug Development Research, 18, 119–144.
Meert, T. & Janssen, P.A.J. (1992). Ritanserin, a new therapeutic approach for drug abuse. Part 2: Effects on cocaine.Drug Development Research, 25, 39–53.
Meert, T. F. (1993). Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.Alcohol and Alcoholism, 28, 157–170.
Meert, T., Awouters, F., Melis, W.J.C., & Janssen, P.A.J. (1990). Ritanserin reduces alcohol preference and alcohol intake in rats given the choice between 3% alcohol and water.Pharmacology: Life Science Advances, 9, 63–69.
Meert, T., Awouters, F., Niemegeers, C.J.E., Schellekens, K.H.L., & Janssen, P.A.J. (1991). Ritanserin reduces abuse of alcohol, cocaine, and fentanyl in rats.Pharmacopsychiatry, 24, 159–163.
Murphy, J.M., McBride, W.J., Lumeng, L., & Li, L.-T. (1988). Effects of serotonin and dopamine agents on ethanol intake of alcohol-preferring P rats.Alcoholism: Clinical and Experimental Research, 12, 306–312.
Naranjo, C. A., Sellers, E. M. & Lawrin, M. O. (1986). Modulation of ethanol intake by serotonin uptake inhibitors.Journal of Clinical Psychiatry, 47, 16–22.
Naranjo, C.A., Sullivan, J.T., Lawrin, M.O. & Sellers, E.M. (1987). Strategies for the identification and testing of new pharmacological modulators of ethanol consumption. In: J. Engel, L. Oreland, D.H. Ingvar, B. Pernow, S. Rössner & L.Å. Pellborn (Eds.),Brain reward systems and abuse. New York: Raven Press, 129–145.
Privette, T.H., Hornsby, R.I., & Meyers, R.D. (1988). Buspirone alters alcohol drinking induced in rats by tetrahydropaveroline injected into brain monoaminergic pathways.Alcohol, 5, 147–152.
Rammsayer, T. & Netter, P. (1988). Effects of changes in brain 5-HT activity on indicators of cortical arousal.International Clinical Psychopharmacology, 3, 231–237.
Rammsayer, T. & Vogel, W. H. (1991). Differential effects of a 5-HT2 receptor blocker on alcohol intake in rats selectively bred for high and low catecholamine responses to stress.Integrative Physiological and Behavioral Science, 26, 189–199.
Schmidt, C.J., Black, C.K., Taylor, V.L., Fadayel, G.M., Humphreys, T.M., Nieduzak, T.R., & Sorensen, S.M. (1992). The 5-HT2 antagonist, MDL 28, 133A, disrupts the serotonergic-dopaminergic interaction mediating the long-term neurochemical effects of 3,4-methylenedioxy-methamphetamine.European Journal of Pharmacology, 220, 151–159.
Schmidt, C.J., Kehne, J.H., Carr, A.A., Fadayel, G.M., Humphreys, T.M., Kettler, H.J., McCloskey, T.C., Padich, R.A., Taylor, V.L., & Sorensen, S.M. (1993). Contribution of serotonin neurotoxins to understanding psychiatric disorders: The role of 5-HT2 receptors in schizophrenia and antipsychotic activity.International Clinical Psychopharmacology, 8, Suppl. 2, 25–32.
Sellers, E. M., Higgins, G. A., & Sobell, M. B. (1992). 5-HT and alcohol abuse.Trends in Pharmacological Sciences, 13, 69–75.
Sorenson, S.M., Humphreys, T.M., Taylor, V.L., & Schmidt, C.J. (1992). 5-HT2 antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis.Journal of Pharmacology and Experimental Therapeutics, 260, 872–878.
Svensson, L., Fahlke, C., Hard, E., & Engel, J.A. (1993). Involvement of the serotonergic system in ethanol intake in the rat.Alcohol, 10, 219–224.
Wise, R. A. (1983). Brain neuronal systems mediating reward processes. In: J.E. Smith & J.D. Lane (Eds.),Neurobiology of opiate reward processes. Amsterdam: Elsevier North Holland Biomedical Press, 405–437.
Wong, D.T., Lumeng, L., Threlkeld, P.G., Reid, L.R., & Li, T.-K. (1988). Serotonergic and adrenergic receptors in alcohol-preferring and nonpreferring rats.Journal of Neural Transmission, 71, 207–218.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rammsayer, T., Vogel, W.H. Ritanserin and voluntary alcohol intake in rats. Integrative Physiological and Behavioral Science 29, 406–414 (1994). https://doi.org/10.1007/BF02691360
Issue Date:
DOI: https://doi.org/10.1007/BF02691360